Fundrise's second fund for stakes in private tech companies registers up to $1 billion of shares
Its registration took effect November 12. It sets a $1,000 minimum and a 2.50% management fee and plans to invest mainly in mid-to-late-stage private companies.
By Funding Desk ·
The short version
- Fundrise Innovation Fund II's registration became effective on November 12, 2026, for up to $1 billion of shares sold continuously at net asset value, which starts at $10.00 a share.
- The prospectus sets a $1,000 minimum, a 2.50% management fee and estimated total annual expenses of 3.60%, assuming $250 million of net assets.
- Investors cannot redeem at will: the fund plans, but is not obliged, to offer quarterly buybacks of generally no more than 5% of net assets.
- Its sister fund ran the same way from 2021 to 2026 before its shares began trading on the New York Stock Exchange as VCX, the prospectus says.
Fundrise, the online investment platform owned by Rise Companies Corp., now has a second registered fund built to buy stakes in privately held technology companies. The registration statement for Fundrise Innovation Fund II, LLC became effective at 9:00 a.m. on November 12, 2026, according to an SEC notice of effectiveness, and the fund put its prospectus, dated November 12, on EDGAR the next day. It covers up to $1 billion of common shares, sold on a continuous basis at net asset value, which starts at $10.00 a share and will fluctuate, with a minimum first investment of $1,000. That is the amount registered, not money raised: the fund is not required to sell any particular number of shares. The prospectus states that neither the SEC nor any state securities regulator has approved or disapproved the shares.
What it plans to buy
Under normal circumstances, the fund is to invest at least 80% of its net assets, plus any investment borrowing, in what it calls Innovation Companies, a list that runs from software, artificial intelligence and semiconductors to fintech, biotech, data centers and aerospace and defense, or in investments that give exposure to them. Its main focus is equity and debt of privately held, mid-to-late-stage growth companies, and it may put up to 20% of net assets into early-stage ones. It expects many of its holdings to be in US companies, and it may keep a stake after a company goes public.
It intends to invest mainly in two ways: directly in companies, and through special purpose and co-investment vehicles that give it access to particular companies. Those vehicles carry their own costs: the prospectus says their annual management fees generally range from 0% to 2%, or one-time upfront fees from 0% to 10%, and that their managers sometimes take carried interest, generally 0% to 20% of realized returns.
Fees, and how investors get out
The adviser, Fundrise Advisors, LLC, is to receive a management fee of 2.50% a year of average daily net assets. There is no sales load. The prospectus estimates total annual operating expenses at 3.60% of net assets, on the assumption that the fund reaches $250 million, and warns that if it raised much less, some expenses would be much higher as a share of net assets. The adviser has agreed, for an initial term of one year, to limit ordinary operating expenses to 4.00% of average daily net assets, excluding items such as interest, taxes, borrowing costs and the fees of other funds it invests in, and it may recoup waived amounts for three years.
| Term | Prospectus |
|---|---|
| Shares registered | Up to $1 billion, sold continuously at net asset value |
| Starting net asset value | $10.00 a share |
| Minimum first investment | $1,000 |
| Management fee | 2.50% a year of average daily net assets |
| Estimated total annual operating expenses | 3.60%, assuming $250 million of net assets |
| Buybacks | Intended quarterly, generally no more than 5% of net assets; not obligatory |
| Exchange listing | Not intended; no secondary market expected |
The fund is a closed-end tender offer fund, so shareholders cannot cash out daily as they can in a mutual fund. It intends, but is not obliged, to offer to buy back shares each quarter, generally for no more than 5% of net assets, and its board may skip or shrink an offer, for example in periods of market stress. It charges no repurchase fee now but may in future charge up to 2.00%. It does not plan to list its shares and expects no secondary market to develop, and it says investors should not consider it a liquid investment.
The first fund's route to the NYSE
The same adviser runs Fundrise Innovation Fund, LLC, which the prospectus says operated as a tender offer fund from 2021 to 2026, when its shares began trading on the New York Stock Exchange under the ticker VCX. Its investment objective and strategy are substantially the same as the new fund's. Before VCX, the adviser's main focus was real estate; with its affiliates it managed about $3.3 billion as of September 18, 2026.
The new fund was organized in Delaware on May 18, 2026, and has no operating history. Its seed financial statements, as of August 12, 2026, show $100,000 of capital, paid by Rise Companies for 10,000 shares at $10.00. It first filed its registration on Form N-2 on June 8, 2026, and amended it six times before it took effect, by our count of its EDGAR filing list. It expects to be taxed as a C corporation for at least its first year.
Unlike the private stock sales that startups report on Form D, the fund is registered with the SEC as an investment company and its prospectus is public. The prospectus also spells out the risks. It calls an investment in the shares speculative and says shareholders may receive little or no return or lose part or all of their investment. It adds that there is no guarantee that its holdings will rise in value, that they may take years to appreciate, and that their market value may fall substantially before the fund can sell them, causing significant losses. The prospectus sets out the full terms, fees and risks.
Sources
- Fundrise Innovation Fund II, LLC, prospectus dated November 12, 2026 (Rule 424(b)(3), file no. 333-296580) U.S. Securities and Exchange Commission (EDGAR), November 13, 2026
- Fundrise Innovation Fund II, LLC, notice of effectiveness, file no. 333-296580 U.S. Securities and Exchange Commission (EDGAR), November 12, 2026
- Fundrise Innovation Fund II, LLC, EDGAR filing list U.S. Securities and Exchange Commission (EDGAR), November 15, 2026
Researched and drafted with AI assistance, then checked against the 3 sources above in a separate fact-check on November 15, 2026. Spotted an error? Tell us.